Patricia joined Moderna in 2020 as President, General Manager to build and lead Moderna’s Canadian operations. She not only secured long-term supply agreements and ensured delivery of COVID-19 vaccines but also co-created a public-private partnership to establish a biomanufacturing facility in Canada and invest in R&D in the country. In Summer 2023, she moved to the Boston area to build and lead the global rare disease business at Moderna. She is a key member of the global commercial leadership team, leading the 2024 Commercial Build strategic initiative, in addition to her commitment to building a novel go to market model for the rare disease business around the world. 

She spent 12 years with GSK in progressively senior roles. She practiced law in a top-tier national firm (Montreal & London UK) and is a member of the Bar of Quebec. She has lived/worked in five different countries. She holds an MBA from HEC Montreal. She currently serves on the Board of Directors of AdMare BioInnovations and of the Canadian Entrepreneurs in New England (CENE).